TGen News & Press Releases

TGen News & Press Releases

TGen looks beyond COVID-19 as it advances pathogen sequencing

Posted Thursday July 15, 2021

Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold

Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID-19

Posted Wednesday July 14, 2021

Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseases

TGen study suggests a variety of factors beyond age influence reaction time

Posted Monday July 12, 2021

Reaction time helps measure healthy vs. diseased brains, revealing potential connections tied to the risk of Alzheimer’s disease and dementia

Helios Education Foundation programs resume in-person instruction this summer at TGen

Posted Tuesday June 8, 2021

Programs for both college and high school students provide advanced training in the biosciences taught by world-class TGen researchers

TGen COVID-19 variant tracking program receives grant from Taiwan Semiconductor Manufacturing Co.

Posted Monday June 7, 2021

TSMC support accelerates TGen’s infectious-disease monitoring of COVID-19 and potential future pandemics

Measuring the effects of radiotherapy on cancer may open up new avenues of treatment

Posted Thursday May 27, 2021

International team identifies biomarker that suggests a better way to monitor radiation therapy

TGen-led study of more than 70,000 individuals links dementia to smoking and cardiovascular disease

Posted Thursday May 13, 2021

Significantly, women impaired more by smoking; men impaired more by cardiovascular disease

When Cold Case Reviews Reveal New Information

Posted Wednesday April 28, 2021

TGen and Illumina Collaboration Looks to Bring More Answers to More Families

TGen identifies gene that could help prevent or delay onset of Alzheimer’s disease

Posted Tuesday April 13, 2021

Boosting ABCC1 could lessen the production of plaque linked to Alzheimer’s development

WENDY’S® JR. FROSTY® PROMOTION BENEFITS TGEN CANCER RESEARCH

Posted Monday April 5, 2021

Prev
[1]
2
3
4
5
Next

Media Contact

Steve Yozwiak
[email protected]
602-343-8704

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive